Extendicare (EXE) Stock Forecast & Price Target

C$10.02 -0.10 (-0.99%)

(As of 05:28 PM ET)

Extendicare - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 3 Analyst Ratings

Sell
0

Hold
2

Buy
1

Based on 3 Wall Street analysts who have issued ratings for Extendicare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 2 have given a hold rating, and 1 has given a buy rating for EXE.

Consensus Price Target

C$10.00
-0.20% Downside

According to the 3 analysts' twelve-month price targets for Extendicare, the average price target is C$10.00. The highest price target for EXE is C$11.00, while the lowest price target for EXE is C$8.50. The average price target represents a forecasted downside of -0.20% from the current price of C$10.02.

Get the Latest News and Ratings for EXE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Extendicare and its competitors.

EXE Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)	1 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	C$10.00	C$9.50	C$9.17	C$7.50
Forecasted Upside	-0.20% Downside	-6.31% Downside	-1.22% Downside	3.16% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Hold

Musk threatens Liberal’s fake “energy crisis” (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now

EXE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EXE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Extendicare Stock vs. The Competition

Type	Extendicare	Medical Companies
Consensus Rating Score	2.33	2.81
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Neutral News See Recent EXE News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/28/2024	Royal Bank of Canada 4 of 5 stars	Boost Target	Sector Perform	C$9.50 ➝ C$11.00	+4.27%
11/14/2024	TD Securities 4 of 5 stars	Boost Target	Hold	C$9.50 ➝ C$10.50	+3.86%
3/11/2024	Leede Jones Gable 0 of 5 stars	Boost Target	Buy	C$7.00 ➝ C$8.50	+16.92%
5/9/2023	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Perform	C$7.00 ➝ C$7.50	+6.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:43 PM ET.

EXE Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Extendicare is C$10.00, with a high forecast of C$11.00 and a low forecast of C$8.50.
: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
: According to analysts, Extendicare's stock has a predicted downside of -0.20% based on their 12-month stock forecasts.
: Extendicare has been rated by research analysts at Royal Bank of Canada, and TD Securities in the past 90 days.
: Analysts like Extendicare less than other "medical" companies. The consensus rating for Extendicare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EXE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Musk threatens Liberal’s fake “energy crisis” (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now

This page (TSE:EXE) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Stock Forecast & Price Target